Virtu KCG Holdings’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Virtu KCG Holdings’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,183	Closed	-$456K	–	3408
2016 Q1	$456K	Buy	3,183 +1,044	+49%	+$148K	0.01%	1289
2015 Q4	$331K	Sell	2,139 -287	-12%	-$41.9K	0.01%	2027
2015 Q3	$347K	Buy	+2,426	New	+$339K	0.01%	1915
2015 Q2	–	Sell	-4,200	Closed	-$592K	–	3854
2015 Q1	$592K	Buy	+4,200	New	+$646K	0.01%	1207
2014 Q4	–	Sell	-1,388	Closed	-$214K	–	4328
2014 Q3	$214K	Buy	+1,388	New	+$209K	﹤0.01%	2827

Other funds holding TARO

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Virtu KCG Holdings's TARO Position: Q2 2016 in Review

Virtu KCG Holdings sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2016, closing a stake of 3,183 shares — an estimated $456K sold.

Virtu KCG Holdings first reported a position in TARO in Q3 2014 and held it in 5 quarters. The position peaked at $592K in Q1 2015. 159 funds tracked by Wall St. Rank hold TARO as of Q2 2016.

Virtu KCG Holdings reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2016 after selling out during the quarter.
Virtu KCG Holdings sold 3,183 Taro Pharmaceutical Industries Ltd. shares in Q2 2016, an estimated $456K.
Virtu KCG Holdings first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2014 and held it in 5 quarters.
Virtu KCG Holdings's Taro Pharmaceutical Industries Ltd. position peaked at $592K in Q1 2015.
159 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2016.

Based on Virtu KCG Holdings's 13F filing for Q2 2016, filed 12 Aug 2016.